According to the US National Data Bank for Rheumatic Diseases, heart failure was significantly less common in anti-TNF-treated patients (2.8%) than in patients treated with disease-modifying antirheumatic drugs (DMARDs) (3.9%) after adjustment for demographic characteristics (60). Here, TNF is linked to heart failure.